India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Local elections across major U.S. cities have kicked off a wave of policy changes that could reshape development costs, rental income, and investment strategies heading into 2026. From NYC’s aggressive tenant‑protection agenda to Chicago’s sustainability push, Miami’s political uncertainty, and Boston’s steady zoning overhaul, the post‑election environment is redefining how real estate professionals, investors, and lenders should prepare for the year ahead.
Insurance carriers are rapidly rolling out AI-related exclusions that strip coverage from claims involving AI tools, automated decision‑making, or generative platforms like ChatGPT and Midjourney. With firms like Berkley and Hamilton introducing sweeping “absolute” and generative‑AI‑specific exclusions, professionals in real estate, mortgage, insurance, and finance now face new liability gaps. As AI becomes unavoidable in everyday work, understanding these exclusions is essential for protecting your career and staying compliant in a fast‑changing risk environment.
Proptech startup Venn has raised a $52 million Series B to unify the entire renting lifecycle into one intelligent platform, replacing over a dozen traditional systems and serving more than half a million tenants. As AI‑powered tools like Venn rapidly reshape property operations, real estate professionals — especially in fast‑moving markets like Florida — will need stronger education and tech‑savvy skills to stay competitive.
Florida’s Gulf Coast is undergoing a dramatic transformation as soaring insurance premiums, costly construction requirements, and the long shadow of Hurricane Ian force middle‑class families, workers, and longtime residents out of communities they once anchored. With premiums topping $5,700 a year — and many paying far more — Realtors warn of looming foreclosures, renters face steep increases, and entire neighborhoods are being rebuilt for wealthier newcomers. This mounting crisis is reshaping the state’s real estate landscape and leaving professionals scrambling to adapt.
Economic uncertainty, rapid tech advances and shifting population patterns are setting the stage for a pivotal year in commercial real estate. New findings from the Counselors of Real Estate, presented at NAR NXT, outline ten major forces reshaping strategy, investment and opportunity in 2026—from policy impacts and portfolio risk to AI adoption, capital flow changes, housing attainability and demographic shifts. This outlook offers clarity and caution for professionals across real estate, mortgage, finance and related fields.
Florida’s home insurance crisis is back in the spotlight as new reforms appear to be repeating decades‑old mistakes. Despite efforts to depopulate Citizens and attract private insurers, many of the companies taking over policies have ties to past insolvencies. Critics say weak oversight, generous ratings, and political influence are allowing unstable insurers to thrive while homeowners pay more for less protection. Experts warn that without transparent ratings, real accountability, and unified regulation, Florida’s insurance market will remain vulnerable—putting property values, lending, and the broader real estate industry at risk.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
